fingolimod hydrochloride has been researched along with mk 2206 in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (mk 2206) | Trials (mk 2206) | Recent Studies (post-2010) (mk 2206) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 355 | 28 | 347 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | mk 2206 (IC50) |
|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.008 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.012 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.065 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CS; de Necochea-Campion, R; Liu, X; Mirshahidi, S; Shouse, G | 1 |
1 other study(ies) available for fingolimod hydrochloride and mk 2206
| Article | Year |
|---|---|
Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Codon; Enzyme Inhibitors; Fingolimod Hydrochloride; Gene Expression Regulation, Leukemic; Heterocyclic Compounds, 3-Ring; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Mutation; Phosphorylation; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt | 2016 |